open access
Treatment of dyslipidemia in diabetes — individualization of therapeutic strategies
open access
Abstract
dyslipidemia are presented, based on PTD guidelines.
The goal of treatment in patients with diabetes
is to decrease LDL-cholesterol level below 2.6 mmol/l
and in patients with diabetes and cardiovascular
disease below 1.8 mmol/l. Desirable values of HDL-C
is > 1.3 mmol/l in women and > 1.0 mmol/l in men,
and of triglycerides < 1.7 mmol/l. Statin is fi rst line
treatment; if targets are not reached combined therapy
with other lipid lowering drugs may be considered, but
this therapy has not been evaluated in CVD and safety
outcome studies.
Abstract
dyslipidemia are presented, based on PTD guidelines.
The goal of treatment in patients with diabetes
is to decrease LDL-cholesterol level below 2.6 mmol/l
and in patients with diabetes and cardiovascular
disease below 1.8 mmol/l. Desirable values of HDL-C
is > 1.3 mmol/l in women and > 1.0 mmol/l in men,
and of triglycerides < 1.7 mmol/l. Statin is fi rst line
treatment; if targets are not reached combined therapy
with other lipid lowering drugs may be considered, but
this therapy has not been evaluated in CVD and safety
outcome studies.
Keywords
diabetic dyslipidemia, diabetes, statins
About this articleTitle
Treatment of dyslipidemia in diabetes — individualization of therapeutic strategies
Journal
Issue
Article type
Review article
Pages
23-29
Published online
2013-04-10
Page views
604
Article views/downloads
5984
DOI
10.5603/cd.34007
Bibliographic record
Diabetologia Kliniczna 2013;2(1):23-29.
Keywords
diabetic dyslipidemia
diabetes
statins
Authors
Barbara Idzior-Waluś
Małgorzata Waluś-Miarka